These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 28784688)

  • 21. Left Ventricular Diastolic Myocardial Stiffness and End-Diastolic Myofibre Stress in Human Heart Failure Using Personalised Biomechanical Analysis.
    Wang ZJ; Wang VY; Bradley CP; Nash MP; Young AA; Cao JJ
    J Cardiovasc Transl Res; 2018 Aug; 11(4):346-356. PubMed ID: 29998358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
    van Heerebeek L; Hamdani N; Falcão-Pires I; Leite-Moreira AF; Begieneman MP; Bronzwaer JG; van der Velden J; Stienen GJ; Laarman GJ; Somsen A; Verheugt FW; Niessen HW; Paulus WJ
    Circulation; 2012 Aug; 126(7):830-9. PubMed ID: 22806632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function.
    Rosas PC; Liu Y; Abdalla MI; Thomas CM; Kidwell DT; Dusio GF; Mukhopadhyay D; Kumar R; Baker KM; Mitchell BM; Powers PA; Fitzsimons DP; Patel BG; Warren CM; Solaro RJ; Moss RL; Tong CW
    Circ Heart Fail; 2015 May; 8(3):582-94. PubMed ID: 25740839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction.
    Selby DE; Palmer BM; LeWinter MM; Meyer M
    J Am Coll Cardiol; 2011 Jul; 58(2):147-54. PubMed ID: 21718911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca2+ entry mode of Na+/Ca2+ exchanger as a new therapeutic target for heart failure with preserved ejection fraction.
    Kamimura D; Ohtani T; Sakata Y; Mano T; Takeda Y; Tamaki S; Omori Y; Tsukamoto Y; Furutani K; Komiyama Y; Yoshika M; Takahashi H; Matsuda T; Baba A; Umemura S; Miwa T; Komuro I; Yamamoto K
    Eur Heart J; 2012 Jun; 33(11):1408-16. PubMed ID: 21490055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.
    Phan TT; Abozguia K; Nallur Shivu G; Mahadevan G; Ahmed I; Williams L; Dwivedi G; Patel K; Steendijk P; Ashrafian H; Henning A; Frenneaux M
    J Am Coll Cardiol; 2009 Jul; 54(5):402-9. PubMed ID: 19628114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.
    Leite S; Rodrigues S; Tavares-Silva M; Oliveira-Pinto J; Alaa M; Abdellatif M; Fontoura D; Falcão-Pires I; Gillebert TC; Leite-Moreira AF; Lourenço AP
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1648-54. PubMed ID: 26408538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF.
    Trum M; Riechel J; Schollmeier E; Lebek S; Hegner P; Reuthner K; Heers S; Keller K; Wester M; Klatt S; Hamdani N; Provaznik Z; Schmid C; Maier L; Arzt M; Wagner S
    Cardiovasc Res; 2024 Jul; 120(9):999-1010. PubMed ID: 38728438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction.
    Hamdani N; Bishu KG; von Frieling-Salewsky M; Redfield MM; Linke WA
    Cardiovasc Res; 2013 Mar; 97(3):464-71. PubMed ID: 23213108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    DeVore AD; McNulty S; Alenezi F; Ersboll M; Vader JM; Oh JK; Lin G; Redfield MM; Lewis G; Semigran MJ; Anstrom KJ; Hernandez AF; Velazquez EJ
    Eur J Heart Fail; 2017 Jul; 19(7):893-900. PubMed ID: 28194841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction.
    Michalski B; Trzciński P; Kupczyńska K; Miśkowiec D; Pęczek Ł; Nawrot B; Lipiec P; Kasprzak JD
    Cardiol J; 2017; 24(1):35-42. PubMed ID: 27748500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wall stress determines systolic and diastolic function--Characteristics of heart failure.
    Alter P; Koczulla AR; Nell C; Figiel JH; Vogelmeier CF; Rominger MB
    Int J Cardiol; 2016 Jan; 202():685-93. PubMed ID: 26454537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac contractility modulation signals improve exercise intolerance and maladaptive regulation of cardiac key proteins for systolic and diastolic function in HFpEF.
    Tschöpe C; Van Linthout S; Spillmann F; Klein O; Biewener S; Remppis A; Gutterman D; Linke WA; Pieske B; Hamdani N; Roser M
    Int J Cardiol; 2016 Jan; 203():1061-6. PubMed ID: 26638055
    [No Abstract]   [Full Text] [Related]  

  • 36. Heart failure with preserved ejection fraction in hypertension.
    Teo LY; Chan LL; Lam CS
    Curr Opin Cardiol; 2016 Jul; 31(4):410-6. PubMed ID: 27070649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of reduced contractility in an animal model of hypertensive heart failure.
    Ward ML; Crossman DJ; Cannell MB
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):711-6. PubMed ID: 21711381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction.
    Pérez Del Villar C; Savvatis K; López B; Kasner M; Martinez-Legazpi P; Yotti R; González A; Díez J; Fernández-Avilés F; Tschöpe C; Bermejo J
    Cardiovasc Res; 2017 Jul; 113(8):906-914. PubMed ID: 28402411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.
    Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK
    Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
    Yeh YH; Wakili R; Qi XY; Chartier D; Boknik P; Kääb S; Ravens U; Coutu P; Dobrev D; Nattel S
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):93-102. PubMed ID: 19808399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.